SPRCNasdaqPharmaceutical PreparationsFiscal year ends December 31
SciSparc Ltd.
Financials through fiscal 2024, year ended Dec 31, 2024Last filing: 20-F on Apr 29, 2026
$1.40−0.30 (-17.65%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 0.1
- Dividend yield
- –
SciSparc statistics
Financials through Jun 30, 2025, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | SciSparc | Industry median |
|---|---|---|
| Market Cap | $511.62K | $197.05M |
| Enterprise Value | -$332.38K | $106.56M |
| PE Ratio | 0.05 | 20.52 |
| PS Ratio | 0.39 | 3.93 |
Enterprise value
| Measure | SciSparc | Industry median |
|---|---|---|
| EV / Sales | -0.25 | 2.69 |
Income (trailing twelve months)
| Measure | SciSparc | Industry median |
|---|---|---|
| Revenue | $1.31M | $57.94M |
| Gross Profit | $506.00K | $90.47M |
| Operating Income | -$7.32M | -$21.44M |
| Pretax Income | -$7.49M | -$14.45M |
| Net Income | -$6.28M | -$22.46M |
| EBITDA | -$6.83M | -$16.91M |
| EPS (Diluted) | $26.88 | -$0.83 |
Margins
| Measure | SciSparc | Industry median |
|---|---|---|
| Gross Margin | 38.7% | 52.3% |
| Operating Margin | -560.2% | -44.5% |
| Pretax Margin | -573.2% | -13.0% |
| Profit Margin | -481.2% | -39.2% |
| EBITDA Margin | -523.3% | -31.3% |
Returns
| Measure | SciSparc | Industry median |
|---|---|---|
| Return on Assets (ROA) | -122.3% | -41.0% |
| Return on Capital Employed (ROCE) | -7243.6% | -37.8% |
Growth
| Measure | SciSparc | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -54.6% | 6.01% |
| EPS Growth (YoY) | -91.1% | -29.2% |
| EPS Growth (3Y CAGR) | -74.1% | -0.17% |
| EPS Growth (5Y CAGR) | 14.9% | 3.77% |
Balance sheet
| Measure | SciSparc | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $1.55M | $62.42M |
| Net Cash (Debt) | $1.55M | $15.68M |
| Net Cash Per Share | $4.23 | $0.65 |
| Equity (Book Value) | -$782.00K | $48.79M |
| Book Value Per Share | -$2.14 | $1.36 |
| Tangible Book Value | -$2.17M | $23.06M |
| Working Capital | -$2.29M | $75.77M |
Financial position
| Measure | SciSparc | Industry median |
|---|---|---|
| Current Ratio | 0.55 | 3.30 |
| Quick Ratio | 0.31 | 2.39 |
| Interest Coverage | -20.73 | -7.12 |
Cash flow (trailing twelve months)
| Measure | SciSparc | Industry median |
|---|---|---|
| Operating Cash Flow | -$5.10M | -$12.35M |
Efficiency
| Measure | SciSparc | Industry median |
|---|---|---|
| Asset Turnover | 0.25 | 0.38 |
| Inventory Turnover | 5.19 | 2.67 |
| Revenue Per Employee | $435.33K | $398.96K |
| Profits Per Employee | -$2.09M | -$732.08K |
| Employee Count | 3 | 73 |
Dividends and yields
| Measure | SciSparc | Industry median |
|---|---|---|
| Earnings Yield | -1228.3% | -21.2% |
| Buyback Yield | -1222.6% | -0.58% |
| Shareholder Yield | -1222.6% | 0.00% |
Shares
| Measure | SciSparc | Industry median |
|---|---|---|
| Shares Outstanding | 365,444 | 59,128,900 |
| Shares Change (YoY) | 1328.8% | 11.1% |
| Float | 308,497 | 48,744,500 |
| Shares Held by Insiders | 15.6% | 11.8% |
Taxes
| Measure | SciSparc | Industry median |
|---|---|---|
| Income Tax | -$14.00K | $91.50K |
Scores
| Measure | SciSparc | Industry median |
|---|---|---|
| Altman Z-Score | -27.89 | 0.10 |
| Piotroski F-Score | 3 | 4 |
Calculated by StockData from SciSparc's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.